Navigation Links
Combination Products Executive Forum to be Hosted by CHI's Pharmaceutical Strategy Series
Date:2/13/2009

Business Executives, Pricing Analysts, and IP Professionals Meet on Expanding their Combination Products Research and Partnerships on June 1-2, 2009 in Cambridge, MA.

Needham, MA (PRWEB) February 13, 2009 -- The Pharmaceutical Strategy Series, a division of Cambridge Healthtech Institute, recently posted details for its next executive forum - Combination Products: Improving Product Life Cycles, Extending Lines, and Creating Novel Therapeutics to be held on June 1-2, 2009 at the Royal Sonesta Hotel in Cambridge, MA. This executive forum will focus on the practical interplay between combination product research, development challenges, and commercial and partnering strategies, as well as the implications for successful market realization.

Session Topics include:

  • Creative Product Development, Portfolio Management, and Line Extension Strategies using Combination Products
  • Regulatory Implications - Anticipating Regulatory Hurdles and New Developments
  • The Market Advantage of Combination Products - Analysis and Strategies for Positioning
  • Commercial Strategies for Success - Market Acceptance and Reimbursement
  • Development Challenges of Combination Products

According to Micah Lieberman, Executive Director of the Pharmaceutical Strategy Series, "We are delighted to have organized this executive forum for the pharmaceutical, biologics and medical devices industries to help companies leverage new business opportunities and intellectual property for their existing (and future) products. Pharmaceutical Strategy Series' executive forums have become known as networking platforms that bring together senior-level executives, analysts, and industry experts. I am also pleased to announce the support of Epstein Becker & Green, P.C. as our sponsor," states Lieberman.

Bradley Merrill Thompson, General Counsel to the Combination Products Coalition and Shareholder at Epstein Becker & Green, P.C. commented: "We look forward to present our perspective on overcoming the regulatory hurdles with combination products. To be compliant and competitive in the marketplace, combination product companies must stay current with regulatory developments and initiatives impacting the combination product industry. Delegates attending this conference will be better positioned to ensure the success of their company's combination products," says Thompson.

Prior to the start of this executive forum will be a pre-conference workshop: Economic Value-Based Product Design for Combination Drugs.

For full details and to register for the conference and/or pre-conference workshop, visit www.healthtech.com/CTX/overview.aspx

To receive a press pass, email Tracey Fielding at tfielding@healthtech.com

About Cambridge Healthtech Institute
Founded in 1992, Cambridge Healthtech Institute (www.chicorporate.com) is the preeminent life science network for leading researchers and business experts from top pharmaceutical, biotech and academic organizations. CHI's portfolio of products includes Cambridge Healthtech Institute Conferences, Insight Pharma Reports, Cambridge Marketing Consultants, Cambridge Meeting Planners and Cambridge Healthtech's Media Group, which includes numerous e-newsletters as well as Bio-IT World magazine.

Founded in 1992, Cambridge Healthtech Institute strives to develop quality information sources that provide valuable new insights and competing points of view while offering balanced coverage of the latest developments. Basic research related to commercial implications is covered, with heavy emphasis placed on end-user insights into new products and technology as well as coverage on the strategy behind the business.

About The Pharmaceutical Strategy Series
A division of Cambridge Healthtech Institute, the Pharmaceutical Strategy Series (www.PharmaSeries.com) produces executive-level conferences that bring together R&D leaders and corporate executives to assess business opportunities, enhance corporate value, and forecast the economic and regulatory landscape within the rapidly changing pharmaceutical & biotechnology industries. PSS conferences are uniquely designed to maximize peer-to-peer networking and idea sharing.

Contact:
James Prudhomme
Cambridge Healthtech Institute
(781) 972-5400

# # #

Read the full story at http://www.prweb.com/releases/2009/02/prweb2051004.htm.


'/>"/>
Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved

Related medicine news :

1. PREZISTA(R) Now Available for Pediatric Patients Six Years of Age and Older as part of HIV Combination Therapy
2. Biomarker Combination and Risk of Ovarian Malignancy Algorithm (Roma(TM)) Demonstrates Accuracy in Detecting Ovarian Cancer
3. If Herceptin is Approved in Combination With Other Emerging Therapies it Will be in a Position to Retain Patient Share From Tykerb/Tyverb for the Treatment of HER2-Positive Breast Cancer
4. Drug combinations key in treating neurodegenerative diseases
5. InterMune Reports Results from Triple Combination Study of ITMN-191
6. Scientists call up stem cell troops to repair the body using new drug combinations
7. DrScore.com Identifies Toxic Combination
8. Galderma Announces Availability of Epiduo(TM) Gel, the First and Only Combination Treatment with a Retinoid and Benzoyl Peroxide to Treat Acne
9. Drug Combinations Putting Seniors at Risk
10. Holiday Treats and Decorations Can Be a Deadly Combination for Pets
11. QLT announces interim results of radical study evaluating Visudyne combination therapy
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... ... October 13, 2017 , ... Coveros, a ... has been awarded a contract by the Center for Medicare and Medicaid Services ... accelerate the enterprise use of Agile methodologies in a consistent and high value ...
(Date:10/12/2017)... , ... October 12, 2017 , ... ... services for healthcare compliance program management, will showcase a range of technology and ... for Assisted Living (NCAL) Convention and Expo to be held October 14–18, 2017 ...
(Date:10/12/2017)... ... October 12, 2017 , ... The ... demand of today’s consumer and regulatory authorities worldwide. From Children’s to Adults 50+, ... to meet the highest standard. , These products are also: Gluten Free, ...
(Date:10/12/2017)... ... 12, 2017 , ... Asante, a nationally recognized health system ... their existing home health joint venture through an agreement, effective October 1, 2017, ... venture home health company with Asante, delivering clinically integrated care, for the past ...
(Date:10/12/2017)... PA (PRWEB) , ... October 12, 2017 , ... ... is the recipient of a 2017 Folio Magazine Eddie Digital Award for ‘Best B-to-B ... York City on October 11, 2017. , The annual award competition recognizes editorial and ...
Breaking Medicine News(10 mins):
(Date:9/23/2017)... Pa. , Sept. 22, 2017 Janssen ... a complete response letter from the U.S. Food and ... seeking approval of sirukumab for the treatment of moderately ... letter indicates additional clinical data are needed to further ... moderately to severely active RA. ...
(Date:9/19/2017)... Sept. 19, 2017   ZirMed Inc ., a recognized ... announced that it has been ranked #1 by its users ... Rankings 2017 User Survey. ZirMed was recognized as the ... hospitals and medical centers over 200 beds and holds one ... technology user survey history. ...
(Date:9/12/2017)... and NEW YORK , Sept. 12, 2017 ... performance ratings for global supply chains, has published the first annual edition ... CSR performance of more than 20,400 companies evaluated by EcoVadis, based on ... 2015 and 2016. ... EcoVadis Global CSR Risk & Performance Index ...
Breaking Medicine Technology: